Progestins prescribed to a large number of women lead to an increased risk of brain tumors, confirm French researchers.
“This is a global public health problem!” warn about Parisian Alain Weil, deputy director of the Epi-Phare group, the health insurance alliance and the National Agency for the Safety of Medicines (ANSM). According to a study conducted by this researcher and his team, “Long-term use of progestone (Surgestone 0.5 mg), medrogestone (Colprona 5 mg), or medroxyprogesterone acetate (Depo-Provera 150 mg/3 ml) is associated with an increased risk of meningioma.”. The results – on the risks of brain tumors associated with these progestins – were published in French last July but were published Wednesday evening in the journal. British[…]
You’ve reached the end of the page, you’re infatuated with Cosette!
Help us support the fights that move you by making a donation so we can continue to maintain free and independent press.
Donate
The rest is reserved for subscribers.
Login to read content
Or
subscribe
Related Posts
The importance of good sleep
The shingles vaccine will be offered free to people 75 years of age and older.
